Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration

Human ceIII ine derived from uterine
adenosquamous carcinoma . Said CEAand
CA125 producing. APPIication
consideration Struktur
CAS-Nr.
Englisch Name:
Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration
Synonyma:
JHUAS-1;Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration
CBNumber:
CB021463158
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration Eigenschaften

Sicherheit

Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration Chemische Eigenschaften,Einsatz,Produktion Methoden

Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangdong Fanpu Biotechnology Co., Ltd. 19513720913
2708713838@qq.com China 4720 58

  • Human ceIII ine derived from uterine adenosquamous carcinoma . Said CEAand CA125 producing. APPIication consideration
  • JHUAS-1
Copyright 2019 © ChemicalBook. All rights reserved